Vancouver scientists have studied 21 biomarkers from 500 tissue samples from women with ovarian Cancer from 1984-2000. Complete article can be found here.
Conclusion from the article
"The association of biomarker expression with survival varies substantially between subtypes, and can easily be overlooked in whole cohort analyses. To avoid this effect, each subtype within a cohort should be analyzed discretely. Ovarian carcinoma subtypes are different diseases, and these differences should be reflected in clinical research study design and ultimately in the management of ovarian carcinoma."
Every Day is a Blessing!